Bioabsorbable Drug-Eluting Stents May Solve Lingering Thrombosis Problem
This article was originally published in The Pink Sheet Daily
Bioabsorbable stents could reduce the risk of chronic inflammation and thrombosis associated with permanent implants, be better suited for pediatric applications, expert suggests at recent CRT conference. Boston Scientific/Riva Medical, Guidant, Biotronik and Biosensors all have bioabsorbable stent projects underway.
You may also be interested in...
Sun protection is not an unheard-of claim in the dietary supplement space, but it has proven a problematic one from regulatory and legal standpoints.
Brands under development and recent acquisitions including EcoFabulous, Costa Brazil and Terasana will account for around 20% of overall 2021 revenue in Amyris’ Consumer business, according to the firm, which aspires to be the “L’Oreal of clean beauty.”
Johnson & Johnson Innovation led a $4.2m Series A financing announced on 25 March, which will help to build out Sunday II Sunday’s hair-care product offering and support in-store distribution in months to come.